Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by gojotv!on Nov 08, 2021 4:34pm
114 Views
Post# 34101964

RE:RE:RE:RE:RE:RE:RE:RE:New documents out on Sedar- Nov 8

RE:RE:RE:RE:RE:RE:RE:RE:New documents out on Sedar- Nov 8

Financials coming up, a worldwide travel BOOM on, and this company does remote-access PCR Covid testing! LOLOL

I love money!!!

gojotv! wrote: Here comes VerifiedLoser with the lies again.
There are no "16M shares". There are only the 8M "milestone-dependent" ones.
Clearly, Care Oncology's performance milestones have been reached, and that, right quickly. With revenue from their Aristotle-tested patients, and enhanced Covid testing revenues from the (not yet peaked) travel BOOM,...
...bashers like Verifried are pooping their panties this morning.
Expect them to gaslight investors all week with outlandish lies.
It's their only hope to keep the price down, now that all indicators have turned against them.
And nothing can make me happier, lol.
GLTA!


 

VerifiedUser123 wrote:

This is an additional 8 million shares they are looking to give away! 


so either total of 16 million shares or $16 million. Absolutely absurd 





<< Previous
Bullboard Posts
Next >>